Development of meloxicam in situ implant formulation by quality by design principle

References

• Suleyman H, Demircan B, Karagoz Y. Anti-inflammatory and side effects of cyclooxygenase inhibitors. Pharmacol Rep 2007;59:247–58
   PubMed Web of Science ®Google Scholar
• Hosie J, Distel M, Bluhmki E. Meloxicam in osteoarthritis: a 6-month, double-blind comparison with diclofenac sodium. Rheumatology 1996;35:39–43
   Web of Science ®Google Scholar
• Han HK, Amidon GL. Targeted prodrug design to optimize drug delivery. AAPS Pharmsci 2000;2:article 6
   Google Scholar
• Ah YC, Choi JK, Choi YK, et al. A novel transdermal patch incorporating meloxicam: in-vitro and in-vivo characterization. Int J Pharm 2010;385:12–19
   PubMed Web of Science ®Google Scholar
• Duangjit S, Opanasopit P, Rojanarata T, Ngawhirunpat T. Characterization and in-vitro skin permeation of meloxicam-loaded liposomes versus transfersomes. J Drug Del 2011;Article ID 418316:9pp
   Google Scholar
• Dunn R. Application of the Atrigel® implant drug delivery technology for patient-friendly, cost-effective product development. Drug Dev Deliv 2003;3:article 2
   Google Scholar
• Tipton AJ, Fujita SM. A biodegradable injectable delivery system for nonsteroidal anti-inflammatory drugs. Pharm Res 1991;9:S–196
   Google Scholar
• Shah NH, Railkar AS, Chen FC, et al. A biodegradable injectable implant for delivering micro and macromolecules using poly (lactic-co-glycolic) acid (PLGA) copolymers. J Control Rel 1993;27:139–47
   Web of Science ®Google Scholar
• Hatefi A, Amsden B. Biodegradable injectable in-situ forming drug delivery systems. J Control Rel 2001;80:9–28
   Web of Science ®Google Scholar
• ICH. Tripartite guideline on pharmaceutical development. International Conference on Harmonization 2009;Q8(R2)
   Google Scholar
• Karnachi AA, Khan MA. Box-Behnken design for the optimization of formulation variables of indomethacin coprecipitates with polymer mixtures. Int J Pharm 1996;131:9–17
   Web of Science ®Google Scholar
• Box GEP, Behnken DW. Some new three level designs for the study of quantitative variables. J Technometrics 1960;2:455–75
   Google Scholar
• Nutan MTH, Soliman MS, Taha EI, Khan MA. Optimization and characterization of controlled release multi-particulate beads coated with starch acetate. Int J Pharm 2005;294:89–101
   PubMed Web of Science ®Google Scholar
• Montgomery DC. Design and analysis of experiments. 4th ed. New York: Wiley; 1996
   Google Scholar
• Singh SK, Dodge J, Durrani MJ, Khan MA. Optimization and characterization of controlled release pellets coated with an experimental latex I. Anionic drug. Int J Pharm 1995;125:243–55
   Web of Science ®Google Scholar
• Yu T, Jagdish S. Controlled delivery of aspirin: effect of aspirin on polymer degradation and in-vitro release from PLGA based phase sensitive systems. Int J Pharm 2008;357:119–25
   PubMedGoogle Scholar
• Bae J, Kim M, Jang C, Lee S. Determination of meloxicam in human plasma using a HPLC method with UV detection and its application to a pharmacokinetic study. J Chromatography B 2007;859:69–73
   PubMed Web of Science ®Google Scholar
• FDA Guidance for industry bioanalytical method validation. Food and Drug Administration [Online] 2001. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070107.pdf [last accessed 15 Jun 2012]
   Google Scholar
• NIH Guide for the Care and Use of Laboratory Animals. US National Institutes of Health 1996 (revised), publication no. 85–23
   Google Scholar
• Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J 2007;22:659–61
   Google Scholar
• Pharmacokinetic Software. Available from: http://www.boomer.org/pkin/soft.html [last accessed 19 Oct 2012]
   Google Scholar
• Wischkel C, Schwendeman SP. Principles of encapsulating hydrophobic drugs in PLA/PLGA. Int J Pharm 2008;364:298–327
   PubMedGoogle Scholar
• Rahman Z, Zidan AS, Habib MJ, Khan MA. Understanding the quality of protein loaded PLGA nanoparticles variability by Plackett--Burman design. Int J Pharm 2010;389:186–94
   PubMed Web of Science ®Google Scholar
• Bodmer D, Kissel T, Traechslin E. Factors influencing the release of peptides and proteins from biodegradable parenteral depot systems. J Control Release 1992;21:129–38
   Web of Science ®Google Scholar
• Tan LP, Venkatraman SS, Sung PF, Wang XT. Effect of plasticization on heparin release from biodegradable matrices. Int J Pharm 2004;283:89–96
   PubMed Web of Science ®Google Scholar
• Gabor F, Ertl B, Wirth M, Mallinger R. Ketoprofen-poly(D,L-lactic-co-glycolic acid) microspheres: influence of manufacturing parameters and type of polymer on the release characteristics. J Microencapsul 1999;16:1–12
   PubMed Web of Science ®Google Scholar
• Chan JM, Zhang L, Yuet KP, et al. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. Biomaterials 2009;30:1627–34
   PubMed Web of Science ®Google Scholar
• Khan KA. The concept of dissolution efficiency. J Pharm Pharmacol 1975;27:48–9
   PubMed Web of Science ®Google Scholar
• Blanco FJ, Guitian R, Moreno J, et al. Effect of antiinflammatory drugs on COX-1 and COX-2 activity in human articular chondrocytes. J Rheumatol 1999;26:1366–73
   PubMed Web of Science ®Google Scholar
• Zolnik BS, Burgess DJ. Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres. J Control Release 2008;127:137–45
   PubMed Web of Science ®Google Scholar
• Galeska I, Kim TK, Patil S, et al. Controlled release of dexamethasone from PLGA microspheres embedded within polyacid-containing PVA hydrogels. AAPS J 2005;7:E231–40
   PubMed Web of Science ®Google Scholar
• Anderson J, Miller K. Biomaterials biocompatibility and the macrophage. Biomaterials 1984;5:5–10
   PubMed Web of Science ®Google Scholar
• Zhao Q, Topham N, Anderson J, et al. Foreign body giant cells and polyurethane biostability: in-vivo correlation of cell adhesion and surface cracking. J Biomed Mater Res 1991;25:177–83
   PubMed Web of Science ®Google Scholar
• van Dijkhuizen-Radersma R, Wright SJ, Taylor LM, et al. In vitro/in vivo correlation for 14C-methylated lysozyme release from poly(ether-ester) microspheres. Pharm Res 2004;21:484–91
   PubMed Web of Science ®Google Scholar
• Ronneberger B, Kao W, Anderson J, Kissel T. In-vivo biocompatibility of ABA triblock copolymers consisting of poly(l-lactic-co-glycolic acid) A blocks attached to central poly(oxyethylene) B blocks. J Biomed Mater Res 1996;30:31–40
   PubMed Web of Science ®Google Scholar